SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer.
Lórand VánczaAnna HorváthLee SeungyeonAndrás RókuszKatalin DezsőAndrea ReszegiGábor PetőváriMartin GötteIlona KovalszkyKornélia BaghyPublished in: Cancers (2023)
Our findings suggest SPOCK1 may be a viable anti-tumor therapeutic target and could be used for monitoring ovarian cancer.